Syndax Pharmaceuticals
SNDX
SNDX
123 hedge funds and large institutions have $938M invested in Syndax Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 38 increasing their positions, 40 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 115 → 123 (+8)
5% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 40
3.13% less ownership
Funds ownership: 104.05% → 100.92% (-3.1%)
Holders
123
Holding in Top 10
5
Calls
$894K
Puts
$389K
Top Buyers
| 1 | +$8.84M | |
| 2 | +$7.91M | |
| 3 | +$7.17M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$7.14M |
| 5 |
Barclays
London,
United Kingdom
|
+$6.59M |
Top Sellers
| 1 | -$27.8M | |
| 2 | -$20.4M | |
| 3 | -$14.5M | |
| 4 |
HM
HealthCor Management
New York
|
-$10.3M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$5.73M |